Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT07766590
NA

Magnesium Oxide and Letrozole Versus Letrozole Alone on Ovarian Response in Insulin Resistant PCOS

Sponsor: Bangladesh Medical University

View on ClinicalTrials.gov

Summary

Does pretreatment with magnesium oxide followed by letrozole increase ovulation rate? What medical problems do participants have when taking drug magnesium oxide and letrozole? Researchers will compare magnesium oxide and letrozole to letrozole alone to see pretreatment with magnesium oxide followed by letrozole works better as ovulation induction. Experimental group will receive magnesium oxide and letrozole alone. Comparator group will receive letrozole alone.

Official title: Effect of Pretreatment With Magnesium Oxide Followed by Letrozole on Ovarian Response in Subfertile Women With Insulin Resistant Polycystic Ovarian Syndrome in Comparison to Letrozole Alone

Key Details

Gender

FEMALE

Age Range

18 Years - 35 Years

Study Type

INTERVENTIONAL

Enrollment

60

Start Date

2025-06-01

Completion Date

2026-05-28

Last Updated

2026-08-14

Healthy Volunteers

No

Interventions

DRUG

Experimental drug: Magnesium oxide (365 mg)

Participants will receive tab magnesium oxide 365mg twice daily for 3months followed by tab letrozole 2.5mg 3 tablets daily at night from 2nd to 6th day of menstruation.

DRUG

Letrozole 2.5mg

Participants will receive 2.5mg of letrozole, 3 tablets at night from 2nd to 6th day of menstruation

Locations (1)

Bangladesh Medical University

Dhaka, Shahbag, Bangladesh